Please assess the completion status of the following clinical trial:

Trial Title: Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* All the patients diagnosed as having cirrhosis of liver~Exclusion Criteria:~* Overt HE or a history of overt HE;~* History of recent (\< 6 weeks) alcohol intake;~* Infection, recent (\< 6 weeks) antibiotic use or gastrointestinal bleeding;~* History of recent (\< 6 weeks) use of drugs affecting psychometric~* Performances like benzodiazepens, antiepileptics, psychotropic drugs;~* History of shunt surgery or transjugular intrahepatic portosystemic shunt for portal hypertension;~* Electrolyte imbalance;~* Renal impairment;~* Presence of hepatocellular carcinoma;~* Severe medical problems such as congestive heart failure, pulmonary disease, neurological or psychiatric disorder, etc., that could influence quality-of-life measurement;~* Inability to perform NP tests and to complete the SIP questionnaire due to bad vision.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).